Brufsky AM - Search Results

1

Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).

Geyer CE Jr, Blum JL, Yothers G, Asmar L, Flynn PJ, Robert NJ, Hopkins JO, O'Shaughnessy JA, Rastogi P, Puhalla SL, Hilton CJ, Dang CT, Gómez HL, Vukelja SJ, Lyss AP, Paul D, Brufsky AM, Colangelo LH, Swain SM, Mamounas EP, Wolmark N. Geyer CE Jr, et al. Among authors: brufsky am. J Clin Oncol. 2024 Apr 20;42(12):1344-1349. doi: 10.1200/JCO.23.01428. Epub 2024 Feb 9. J Clin Oncol. 2024. PMID: 38335467

2

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer.

Low JA, Wedam SB, Lee JJ, Berman AW, Brufsky A, Yang SX, Poruchynsky MS, Steinberg SM, Mannan N, Fojo T, Swain SM. Low JA, et al. J Clin Oncol. 2005 Apr 20;23(12):2726-34. doi: 10.1200/JCO.2005.10.024. J Clin Oncol. 2005. PMID: 15837987 Clinical Trial.

3

Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer.

Brufsky A, Harker WG, Beck JT, Carroll R, Tan-Chiu E, Seidler C, Hohneker J, Lacerna L, Petrone S, Perez EA. Brufsky A, et al. J Clin Oncol. 2007 Mar 1;25(7):829-36. doi: 10.1200/JCO.2005.05.3744. Epub 2006 Dec 11. J Clin Oncol. 2007. PMID: 17159193 Clinical Trial.

4

Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.

Bender CM, Sereika SM, Brufsky AM, Ryan CM, Vogel VG, Rastogi P, Cohen SM, Casillo FE, Berga SL. Bender CM, et al. Among authors: brufsky am. Menopause. 2007 Nov-Dec;14(6):995-8. doi: 10.1097/gme.0b013e318148b28b. Menopause. 2007. PMID: 17898668 Free PMC article.

5

RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer.

O'Shaughnessy JA, Brufsky AM. O'Shaughnessy JA, et al. Among authors: brufsky am. Clin Breast Cancer. 2008 Aug;8(4):370-3. doi: 10.3816/CBC.2008.n.045. Clin Breast Cancer. 2008. PMID: 18757267 No abstract available.

6

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Lin NU, Diéras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, Roché H, Liu MC, Greil R, Ciruelos E, Loibl S, Gori S, Wardley A, Yardley D, Brufsky A, Blum JL, Rubin SD, Dharan B, Steplewski K, Zembryki D, Oliva C, Roychowdhury D, Paoletti P, Winer EP. Lin NU, et al. Clin Cancer Res. 2009 Feb 15;15(4):1452-9. doi: 10.1158/1078-0432.CCR-08-1080. Clin Cancer Res. 2009. PMID: 19228746 Clinical Trial.

7

Bevacizumab in breast cancer: the best is yet to come?

Puhalla S, Brufsky A. Puhalla S, et al. Oncology (Williston Park). 2009 Apr 15;23(4):332, 335. Oncology (Williston Park). 2009. PMID: 19476262 Free article. No abstract available.

8

Trastuzumab-based therapy for patients with HER2-positive breast cancer: from early scientific development to foundation of care.

Brufsky A. Brufsky A. Am J Clin Oncol. 2010 Apr;33(2):186-95. doi: 10.1097/COC.0b013e318191bfb0. Am J Clin Oncol. 2010. PMID: 19675448 Review.

9

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer.

Puhalla S, Brufsky A. Puhalla S, et al. Biologics. 2008 Sep;2(3):505-15. doi: 10.2147/btt.s3539. Biologics. 2008. PMID: 19707381 Free PMC article.

10

Adjuvant endocrine therapy for premenopausal women with breast cancer.

Puhalla S, Brufsky A, Davidson N. Puhalla S, et al. Breast. 2009 Oct;18 Suppl 3(0 3):S122-30. doi: 10.1016/S0960-9776(09)70286-3. Breast. 2009. PMID: 19914530 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page